HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A double blind trial with oxamniquine in chronic schistosomiasis mansoni.

Abstract
Ninety-one children with chronic schistosomiasis mansoni were selected for this double blind trial. 48 (Group 1) were treated with a single oral dose of oxamniquine (20mg/kg body-weight) and 43 (Group 2) received the placebo. Clinical, laboratory and radiological examinations were performed before and after treatment. Dark urine and vomiting were observed only in the oxamniquine group. Pulmonary condensations with or without air bronchogram were observed in the chest X-ray of 15% of Group 1 patients, between days 3 and 5 after treatment. In the urinalysis made on the first day after treatment, a false positive reaction was reported for urobilinogen and bilirubin in up to 50% of the patients treated with oxamniquine. In Group 1, 69.6% of the patients were cured. No patient was cured in Group 2. There was a 4.4% incidence of infection in the control group. There was a 77.9% egg excretion reduction in the 14 Group 1 patients not cured by oxamniquine. The authors conclude that oral oxamniquine in the prescribed dosage, has low toxicity and good therapeutic efficacy in children with chronic schistosomiasis mansoni.
AuthorsJ R Lambertucci, D B Greco, E R Pedroso, M O da Costa Rocha, H M Salazar, D P de Lima
JournalTransactions of the Royal Society of Tropical Medicine and Hygiene (Trans R Soc Trop Med Hyg) Vol. 76 Issue 6 Pg. 751-5 ( 1982) ISSN: 0035-9203 [Print] England
PMID6761905 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Nitroquinolines
  • Oxamniquine
Topics
  • Adolescent
  • Child
  • Chronic Disease
  • Clinical Trials as Topic
  • Double-Blind Method
  • Feces (parasitology)
  • Female
  • Humans
  • Intestinal Diseases, Parasitic (drug therapy)
  • Liver Diseases, Parasitic (drug therapy)
  • Male
  • Nitroquinolines (therapeutic use)
  • Oxamniquine (therapeutic use)
  • Parasite Egg Count
  • Schistosoma mansoni
  • Schistosomiasis (drug therapy, parasitology)
  • Splenic Diseases (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: